Cargando…
High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer
Targeting exosome biogenesis and release may have potential clinical implications for cancer therapy. Herein, we have optimized a quantitative high throughput screen (qHTS) assay to identify compounds that modulate exosome biogenesis and/or release by aggressive prostate cancer (PCa) CD63-GFP-expres...
Autores principales: | Datta, Amrita, Kim, Hogyoung, McGee, Lauren, Johnson, Adedoyin E., Talwar, Sudha, Marugan, Juan, Southall, Noel, Hu, Xin, Lal, Madhu, Mondal, Debasis, Ferrer, Marc, Abdel-Mageed, Asim B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970137/ https://www.ncbi.nlm.nih.gov/pubmed/29802284 http://dx.doi.org/10.1038/s41598-018-26411-7 |
Ejemplares similares
-
Estradiol-ERβ2 signaling axis confers growth and migration of CRPC cells through TMPRSS2-ETV5 gene fusion
por: Kim, Hogyoung, et al.
Publicado: (2016) -
Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma
por: Greenberg, Jacob W., et al.
Publicado: (2021) -
Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer
por: Khurana, Namrata, et al.
Publicado: (2017) -
Latent HIV-Exosomes Induce Mitochondrial Hyperfusion Due to Loss of Phosphorylated Dynamin-Related Protein 1 in Brain Endothelium
por: Chandra, Partha K., et al.
Publicado: (2021) -
Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells
por: Khurana, Namrata, et al.
Publicado: (2020)